| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/20/2009 | CA2396678C Peptide derivatives and their pharmaceutically acceptable salts, processes for preparation of both, and use thereof |
| 01/20/2009 | CA2392721C Intervertebral disc treatment devices and methods |
| 01/20/2009 | CA2352389C An oral formulation for gastrointestinal drug delivery |
| 01/20/2009 | CA2305621C Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties |
| 01/20/2009 | CA2271693C Guanylhydrazones useful for treating diseases associated with t cell activation |
| 01/20/2009 | CA2264570C Invasion-inducing agents and invasion-inhibitors for use in wound healing and cancer |
| 01/20/2009 | CA2236263C Methods for use of mpl ligands with primitive human stem cells |
| 01/20/2009 | CA2108473C Heregulins (hrgs) binding proteins of p185erb2 |
| 01/15/2009 | WO2009009782A2 Cynomolgus il-17 proteins, antibodies, compositions, methods and uses |
| 01/15/2009 | WO2009009775A1 Pharmaceutical polypeptide dry powder aerosol formulation and method of preparation |
| 01/15/2009 | WO2009009739A2 Methods and compositions for facilitating cell death of cancer stem cells and for treating cancer |
| 01/15/2009 | WO2009009727A2 Ghrh analogs and therapeutic uses thereof |
| 01/15/2009 | WO2009009587A2 Apoptosis-modulating protein therapy for proliferative disorders and nanoparticles containing the same |
| 01/15/2009 | WO2009009562A2 Glp-1-fc fusion protein formulation |
| 01/15/2009 | WO2009009434A1 Polymers and uses thereof |
| 01/15/2009 | WO2009009396A2 Bri polypeptides and reducing ab aggregation |
| 01/15/2009 | WO2009009378A2 Cathepsin-d neuroprotection |
| 01/15/2009 | WO2009009173A2 Klotho-beta for use in treating cancer, liver disorders, gallstones, wasting syndrome and obesity-related diseases |
| 01/15/2009 | WO2009009156A2 Use of hydrolytic and oxidative enzymes to dissolve biofilm in airway passages |
| 01/15/2009 | WO2009009115A2 Liposome compositions for treatment of hepatitis c |
| 01/15/2009 | WO2009009065A1 Biofilm prevention using lactoferrin |
| 01/15/2009 | WO2009009035A1 Somatostatin analog and uses thereof |
| 01/15/2009 | WO2009009034A2 Methods and compositions useful in the treatment of mucositis |
| 01/15/2009 | WO2009008719A2 Treatment and prevention of inflammatory diseases and autoimmune diseases |
| 01/15/2009 | WO2009008714A1 Food compositions |
| 01/15/2009 | WO2009008713A1 Tap-inhibitors from old world primate 1-herpesviruses and their use |
| 01/15/2009 | WO2009008595A1 Pharmaceutical liquid composition of botulinum toxin with improved stability |
| 01/15/2009 | WO2009008511A1 Normal-pressure glaucoma model and method of evaluating test substance by using the same |
| 01/15/2009 | WO2009007992A2 Pharmaceutical composition produced by microprecipitation |
| 01/15/2009 | WO2009007848A2 Bioactive peptides and method of using same |
| 01/15/2009 | WO2009007746A2 Treatment of sensorineural hearing loss |
| 01/15/2009 | WO2009007714A2 Human pancreatic polypeptide (hpp) analogues and their effects on feeding behaviour |
| 01/15/2009 | WO2009007661A2 Use of a chromatography substrate for reducing the amount of adamts13 in a solution derived from plasma |
| 01/15/2009 | WO2009007532A2 Use of a haemoglobin for the preparation of dressings and resulting dressings |
| 01/15/2009 | WO2009007120A2 Tnf superfamily collectin fusion proteins |
| 01/15/2009 | WO2009007112A2 Thrombomodulin for increasing reperfusion and preventing blood vessels obstruction |
| 01/15/2009 | WO2009007080A1 Method of preventing and treating acute brain pathologies |
| 01/15/2009 | WO2009006732A1 Bifunctional fusion proteins of the alpha-melanocyte stimulating hormone (alpha-msh) and atrial natriuretic protein (anp) and uses in hypertension and acute kidney injury |
| 01/15/2009 | WO2009006700A1 Immunology treatment for biofilms |
| 01/15/2009 | WO2009006686A1 Synergistic mixture |
| 01/15/2009 | WO2008148105A8 Endometrial stem cells and methods of making and using same |
| 01/15/2009 | WO2008140632A3 Polypeptides for inducing a protective immune response against staphylococcus epidermidis |
| 01/15/2009 | WO2008140586A3 Modulation of rhamm (cd168) for selective adipose tissue development |
| 01/15/2009 | WO2008140574A3 Radiation protection and treatment for exposure to gamma-radiation |
| 01/15/2009 | WO2008140499A3 Method for treating sepsis |
| 01/15/2009 | WO2008130803A3 Pulmonary delivery of spherical insulin microparticles |
| 01/15/2009 | WO2008124166A3 Fusion proteins of collagen-binding domain and parathyroid hormone |
| 01/15/2009 | WO2008121154A3 Nucleic acid sequences for biosynthesis of non -mccj25-related lariat peptides |
| 01/15/2009 | WO2008110578A3 Markers, antibodies and recombinant scfvs for mesenchymal stem cell-sub-populations and osteoclasts |
| 01/15/2009 | WO2008103318A3 The adipocyte secreted protein ccdc80 is a potent stimulator of bone formation |
| 01/15/2009 | WO2008097854A4 Method and substances for treating hpv infection |
| 01/15/2009 | WO2008073160A3 Methods for converting or inducing protective immunity |
| 01/15/2009 | WO2008017066A3 Phytases with improved thermal stability |
| 01/15/2009 | WO2008016404A3 Parathyroid hormone analogues and uses thereof |
| 01/15/2009 | WO2007101602A9 Chimeric kunitz domains and their use |
| 01/15/2009 | US20090019557 Fgf2-related methods for diagnosing and treating depression |
| 01/15/2009 | US20090018481 Plaster which releases active compound |
| 01/15/2009 | US20090018413 Implantable medical device for diagnostic sensing |
| 01/15/2009 | US20090018406 Method and Device for Assessing Carbohydrate-to-Insulin Ratio |
| 01/15/2009 | US20090018314 low affinity receptor for IgE (FceRII/CD23); for modulating or inhibiting induced IgE expression; allergic conditions, autoimmune and inflammatory diseases |
| 01/15/2009 | US20090018198 Method for treating a motoneuron disorder |
| 01/15/2009 | US20090018087 Neuronal disorders such as Alzheimer's disease, Down Syndrome, Parkinson disease, Chorea Huntington, pathogenic psychotic conditions, schizophrenia, impaired food intake, sleep-wakefulness, impaired homeostatic regulation of energy metabolism, impaired autonomic function; alcoholism |
| 01/15/2009 | US20090018086 Monomethylvaline Compounds Having Phenylalanine Side-Chain Replacements at the C-Terminus |
| 01/15/2009 | US20090018085 Use of a GnRH antagonist peptide in the treatment of sex hormone-dependent diseases |
| 01/15/2009 | US20090018084 Methods of restoring cognitive ability using non-peptidic compounds |
| 01/15/2009 | US20090018083 Methods and compositions for inhibition of bcl6 repression |
| 01/15/2009 | US20090018082 Use of Factor VIIa or Factor VIIa Equivalents for Treating Trauma |
| 01/15/2009 | US20090018081 Activatable clostridial toxins |
| 01/15/2009 | US20090018080 Methods for treating viral infection using il-28 and il-29 cysteine mutants |
| 01/15/2009 | US20090018079 Optimized dna and protein sequence of an antibody to improve quality and yield of bacterially expressed antibody fusion proteins |
| 01/15/2009 | US20090018078 Apoptosis-Modulating Protein Therapy for Proliferative Disorders and Nanoparticles Containing the Same |
| 01/15/2009 | US20090018077 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018076 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018073 Administering polypeptide of growth factor to increase mitogenesis; bind to receptors and increase cell differentiation and survival |
| 01/15/2009 | US20090018072 High protein supplement |
| 01/15/2009 | US20090018071 Epididymis-specific receptor protein |
| 01/15/2009 | US20090018070 Fsh Mutants |
| 01/15/2009 | US20090018069 Methods and Compositions Related to Mutant Kunitz Domain I of Tfpi-2 |
| 01/15/2009 | US20090018068 G-protein coupled receptors |
| 01/15/2009 | US20090018067 Regulatory t cell epitopes, compositions and uses thereof |
| 01/15/2009 | US20090018066 Pharmaceutical compositions for modulating the activity of a novel triglyceride hydrolase |
| 01/15/2009 | US20090018065 Plant PR-5 proteins as mammalian therapeutic agents |
| 01/15/2009 | US20090018064 Regulation of mineral and skeletal metabolism |
| 01/15/2009 | US20090018063 Compositions and methods for the treatment of disorders involving epithelial cell apoptosis |
| 01/15/2009 | US20090018062 Malignant tumor-inhibiting preparation comprising des a fibrin |
| 01/15/2009 | US20090018061 Compositions and Methods for Treating Cardiac Conditions |
| 01/15/2009 | US20090018060 Thymus-specific protein |
| 01/15/2009 | US20090018059 Method for maintaining pluripotency of stem/progenitor cells |
| 01/15/2009 | US20090018058 Vitamin D Receptor Modulators |
| 01/15/2009 | US20090018057 OIL IN WATER EMULSION COMPRISING NSAIDs AND QUATERNARY AMMONIUM HALIDES |
| 01/15/2009 | US20090018056 Heteroarylcarbamoylbenzene derivatives |
| 01/15/2009 | US20090018055 [6,5]-bicyclic gpr119 g protein-coupled receptor agonists |
| 01/15/2009 | US20090018054 Cholesteryl Ester Transfer Protein Inhibitors |
| 01/15/2009 | US20090018053 Formulations for amylin agonist peptides |
| 01/15/2009 | US20090018052 Treatment of Diabetes and Related Pathologies |
| 01/15/2009 | US20090018030 Polymorphisms in the human genes for OCT1 and their use in diagnostic and therapeutic applications |
| 01/15/2009 | US20090017559 Methods for diagnosing renal disorders |
| 01/15/2009 | US20090017558 Apolipoprotein e stable folding intermediate and methods of use thereof |
| 01/15/2009 | US20090017522 proteolytic fragment of a growth differentiation factor (GDF) polypeptide (pro-GDF) or a functional peptide portion thereof; affects activity associated with GDF signal transduction |
| 01/15/2009 | US20090017502 Interferon-alpha polypeptides and conjugates |